Effect of a 8 and 12-week exercise program on aerobic capacity after percutaneous revascularization in subjects with Acute Coronary Syndromes

Not Applicable

Recruiting

• Conditions: Acute Coronary Syndromes; Cardiovascular - Coronary heart disease

• Registration Number: ACTRN12620000363987
• Lead Sponsor: Juan Carlos Sánchez Delgado

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-03-16
• Last Update Posted: 23 March 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Subjects over 18 years, residing in Bucaramanga during the study and who are referred to a cardiac rehabilitation program-Phase II, after having undergone percutaneous revascularization for a first coronary event.

Exclusion Criteria

All subjects who have received or are receiving phase II cardiac rehabilitation treatment after percutaneous revascularization. In addition, those who have absolute or relative contraindications for the performance of physical exercise or the functional capacity test. Finally subjects who doesnt complete the 80% of the programmed physical exercise sessions will be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcome: Functional capacity (Mets/Vo2 max)<br>Instruments: 6 minutes walking test [Initial assessment (T0): Previous the beginning of the intervention.<br>Second assessment (T1): 8 weeks post commencement of intervention<br>Third assessment (T2): 12 weeks post commencement of intervention<br><br>no primary timepoint is stablished ]

Secondary Outcome Measures

Name	Time	Method
Adverse cardiovascular events, such as: Dyspnea, syncope, nausea and heart attack. They will be assessed through clinical examination and participant self-reported. [only if presented, they will be assessed for the 12 weeks of the study]